We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Precision Optics Corporation, Inc. Common stock

Company price
5.07 USD 0.02 ( 0.40%)
Last update at 2026-11-12T15:41:00Z
VOLUME
4394
Market Cap
39.87M

Momentum Score

…

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
5.07
Low
5.20
High
52 Week Price Range
5.12
Low
6.95
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Precision Optics Corporation (POCI) is a Nasdaq-listed company; publicly available disclosures are limited, preventing a detailed, verifiable description of its operations or product lines. Long-term growth drivers are not clearly documented; investors may benefit if the company clarifies strategy and demonstrates execution, but prospects hinge on improved transparency and operational progress.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
5.05
Dividend Yield
-
Revenue TTM
19.41M
Revenue Per Share
3.24
Gross Profit TTM
7.73M
Debt / Equity
0.26
ROE
-15.62%
Net Debt
0.23M
ROCE
-4.41%
Diluted EPS TTM
-0.27

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -0.14M -0.93M -0.10M -1.42M -0.61M
Net income -0.14M -0.93M -0.10M -1.43M -0.61M
Selling general administrative 7.38M 5.61M 3.71M 3.90M 2.10M
Gross profit 7.73M 4.93M 3.43M 3.36M 2.12M
Reconciled depreciation 0.21M 0.19M 0.15M 0.11M 0.04M
Ebit -0.64M -1.35M -0.91M -1.42M -0.48M
Ebitda -0.43M -1.16M -0.76M -1.31M -0.45M
Depreciation and amortization 0.21M 0.19M 0.15M 0.11M 0.04M
Operating income -0.64M -1.35M -0.91M -1.42M -0.48M
Other operating expenses 21.68M 17.03M 11.58M 11.35M 7.29M
Interest expense 0.22M 0.16M 0.01M 0.00M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -0.22M -0.16M -0.01M -0.00M -0.00M
Income tax expense 0.00M 0.00M 0.00M 0.00M 0.00M
Total revenue 21.04M 15.68M 10.67M 9.92M 6.80M
Total operating expenses 8.37M 6.28M 4.34M 4.79M 2.61M
Cost of revenue 13.31M 10.75M 7.24M 6.56M 4.68M
Total other income expense net 0.71M 0.42M 0.80M -0.00M -0.13M
Net income from continuing ops -0.14M -0.93M -0.10M -1.43M -0.61M
Net income applicable to common shares -0.14M -0.93M -0.10M -1.43M -0.61M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 19.74M 16.70M 6.26M 6.35M 7.49M
Intangible assets 0.27M 0.23M 0.14M 0.10M 0.05M
Other current assets 0.25M 0.21M 0.15M 0.13M 0.18M
Total liab 7.69M 7.73M 2.83M 3.58M 4.12M
Total stockholder equity 12.05M 8.97M 3.43M 2.77M 3.38M
Other current liab 0.93M 0.88M 0.76M 0.75M 1.98M
Common stock 0.06M 0.17M 0.13M 0.13M 0.12M
Capital stock 0.06M 0.17M 0.13M 0.13M 0.12M
Retained earnings -48.24M -48.09M -47.17M -47.06M -45.64M
Other liab - 0.71M 0.17M 0.33M 0.50M
Good will 8.82M 8.82M 0.69M 0.69M 0.69M
Cash 2.93M 0.61M 0.86M 1.13M 2.29M
Total current liabilities 5.26M 4.59M 2.51M 3.15M 3.61M
Current deferred revenue 1.17M 0.91M 0.45M 0.42M 0.45M
Net debt 0.23M 2.39M -0.61M -0.12M -2.27M
Short term debt 0.73M 0.56M 0.10M 0.92M 0.01M
Short long term debt 0.51M 0.37M - 0.81M -
Short long term debt total 3.16M 3.00M 0.25M 1.01M 0.01M
Other stockholder equity 60.22M 56.90M 50.46M 49.70M 48.89M
Property plant equipment 0.79M 1.15M 0.66M 0.62M 0.38M
Total current assets 9.86M 6.51M 4.78M 4.95M 6.37M
Net tangible assets 2.96M -0.08M 2.60M 1.99M 2.64M
Net receivables 3.91M 2.66M 1.88M 1.48M 2.17M
Long term debt 2.18M 1.96M - - -
Inventory 2.78M 3.02M 1.89M 2.20M 1.73M
Accounts payable 2.43M 2.24M 1.21M 1.07M 1.17M
Non currrent assets other -3.60M - - - -
Non current assets total 9.88M 10.20M 1.48M 1.40M 1.12M
Capital lease obligations 0.47M 0.67M 0.25M 0.21M 0.01M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.05M -0.41M -0.29M -1.60M -0.04M
Change to liabilities 0.46M 0.45M 0.17M -0.14M -0.36M
Total cashflows from investing activities -0.05M -0.41M -0.12M -1.60M -0.04M
Net borrowings 0.34M -0.29M -0.06M 0.77M -0.01M
Total cash from financing activities 2.45M 1.09M -0.03M 1.04M 2.96M
Change to operating activities 0.17M -0.08M -0.01M 0.09M 0.01M
Net income -0.14M -0.93M -0.10M -1.43M -0.61M
Change in cash 2.32M -0.26M -0.27M -1.15M 1.89M
Begin period cash flow 0.61M 0.86M 1.13M 2.29M 0.40M
End period cash flow 2.93M 0.61M 0.86M 1.13M 2.29M
Total cash from operating activities -0.08M -0.93M 0.05M -0.59M -1.03M
Issuance of capital stock 2.29M 1.50M 0.24M 0.27M 2.92M
Depreciation 0.21M 0.19M 0.15M 0.11M 0.04M
Change to inventory 0.25M -0.68M 0.31M -0.46M 0.14M
Change to account receivables -1.24M -0.11M -0.40M 0.68M -0.72M
Other cashflows from financing activities 0.57M -0.13M -0.17M 0.82M 0.04M
Change to netincome 0.22M 0.23M -0.08M 0.55M 0.48M
Capital expenditures 0.05M 0.15M 0.12M 0.16M 0.15M
Change in working capital -0.36M -0.42M 0.07M 0.17M -0.94M
Stock based compensation 0.92M 0.92M 0.73M 0.50M 0.47M
Other non cash items -0.70M -0.69M -0.81M 0.04M 0.01M
Free cash flow -0.13M -1.09M -0.08M -0.75M -1.18M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
POCI
Precision Optics Corporation, Inc. Common stock
0.02
0.40%
5.07 - - 1.72 2.93 1.82 -27.04
ISRG
Intuitive Surgical Inc
-8.88
1.97%
440.65 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme
-2.56
1.26%
200.18 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA
-1.98
1.94%
99.87 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company
0.83
0.39%
215.35 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Precision Optics Corporation, Inc. Common stock

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

22 East Broadway, Gardner, MA, United States, 01440

978 630 1800

84

Name Title Year Born
Dr. Joseph N. Forkey CEO, Pres, Treasurer & Director 1968
Mr. Daniel S. Habhegger CFO & Company Sec. 1970
Mr. Jeffrey L. DiRubio Sr. VP of Sales & Marketing NA
Mr. Richard E. Forkey Founder, Advisor to the CEO & Director Emeritus 1940
Mr. John Hargraves Director of Operations NA
Mr. Bruce Radl Director of Technology Devel. NA
Mr. Donald A. Major Consultant 1961
Mr. Divaker Mangadu Pres of Ross Optical Division NA
Mr. Richard G. Cyr Optics Laboratory Mang. NA
Dr. Joseph N. Forkey CEO, President, Treasurer & Director 1968

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…